OUR FOCUS

Developing next generation peptide therapeutics for obesity and liver disease

OUR PIPELINE

Our diverse pipeline includes treatments for obesity, NASH (ALT-801), and chronic Hepatitis B (HepTcell™). In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.

OBESITY AND LIVER THERAPIES

INTRANASAL VACCINES & THERAPEUTICS